Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutathione reductase, mitochondrial is an essential flavoprotein enzyme encoded by the GSR gene. It catalyzes the reduction of glutathione disulfide (GSSG) into two molecules of reduced glutathione (GSH), using NADPH as an electron donor. This reaction maintains high intracellular levels of GSH—a critical antioxidant that protects cells from reactive oxygen species and supports various metabolic processes including detoxification, protein synthesis, DNA repair, and maintenance of iron-sulfur cluster enzymes. The enzyme functions primarily within mitochondria but also exists in cytosolic forms depending on organismal context. Its proper function is vital for cell survival under aerobic conditions; deficiency leads to impaired respiration rates and increased sensitivity to oxidative stress-related diseases such as cancer and neurodegeneration.
Drugs that inhibit or modulate this enzyme typically act by blocking its active site or interfering with NADPH/FAD binding, leading to increased cellular oxidative stress and potential cell death—useful for cancer therapy but also a risk for toxicity.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione reductase, mitochondrial (GSR).